Should you choose DASH or Nordic diets to slow ageing?
If you already eat reasonably well, should a study linking DASH and Nordic diets to slower epigenetic ageing change your shopping list? For anyone over 40 trying to preserve health and independence, that is a more useful question than which diet tops another ranking. The answer depends on what researchers measured, and whether the result tells us anything about the benefits of switching.
Emerging evidence: a dietary association, without an assigned diet
Researchers at the German Centre for Neurodegenerative Diseases and collaborating institutions compared ten dietary scores with blood-based epigenetic ageing measures. Their 2026 analysis included 6,470 Rhineland Study participants, averaging 56 years old, with replication analyses in 1,034 EPIC-Potsdam participants. Food questionnaires captured reported eating habits; nobody was assigned a diet. Tavares and colleagues, 2026.
In the Rhineland analysis, higher DASH and Nordic scores were associated with favourable results across all three measures: GrimAge acceleration, PhenoAge acceleration and DunedinPACE. These associations survived correction for multiple comparisons. That statistical consistency deserves attention, but does not establish clinical superiority.
The analysis was cross-sectional. It compared dietary habits and molecular measurements around the same period, rather than tracking the effects of switching diets. Adjustments for factors including smoking and energy intake cannot eliminate all confounding. People’s health may also influence what they eat.
For your decision, the missing comparison is crucial: would changing from an already healthy diet to DASH or Nordic eating improve future health? This study did not test that. Study methods and results.
What an ageing clock can tell you
Epigenetic measures use patterns of DNA methylation, chemical marks on DNA, to estimate aspects of biological ageing. They condense complex information into a number, which makes them useful for research but easy to overinterpret.
DunedinPACE, for example, was developed using repeated measurements of 19 indicators of organ-system health in a New Zealand birth cohort. Researchers then identified a blood methylation pattern that approximated those longitudinal changes. Validation linked the resulting measure with outcomes including disease, disability and mortality. This gives the marker a basis in observed health trajectories. It does not establish that deliberately lowering its score will prevent those outcomes. Belsky and colleagues, Columbia University and collaborators, 2022.
That distinction remains even when researchers conduct an intervention.
In a 2023 analysis of the randomised CALERIE trial, two years of calorie restriction slowed DunedinPACE on average, while the PhenoAge and GrimAge measures did not show significant treatment effects. The investigators explicitly identified the need for longer follow-up to establish whether the molecular change translated into less disease or longer healthy life. Waziry and colleagues, Columbia University and collaborators, 2023.
This is a reason to interpret clocks carefully, not a recommendation to restrict calories. Different measures can respond differently to the same intervention. A favourable result does not tell you how many additional years you will live, whether your memory will improve, or whether everyday tasks will become easier.
Established evidence gives more specific reasons to choose a diet
DASH has a practical advantage when discussing evidence: its name identifies the original target, Dietary Approaches to Stop Hypertension. Researchers tested it against a measurable outcome.
In the landmark 1997 randomised feeding trial, 459 adults received one of three diets for eight weeks after a run-in period. The DASH combination diet emphasised fruit, vegetables and low-fat dairy, with less saturated and total fat. Compared with the control diet, it lowered systolic blood pressure by an average of 5.5 mmHg and diastolic pressure by 3.0 mmHg. Body weight and sodium intake were held constant. Appel and the DASH Collaborative Research Group, Johns Hopkins University and collaborators, 1997.
That is established evidence of a blood-pressure effect under the trial’s conditions. It is neither a guaranteed individual response nor evidence of added lifespan. Nevertheless, it provides a more direct basis for discussing DASH with a clinician than its position in an epigenetic ranking.
Nordic dietary research offers another specific comparison. The 2013 SYSDIET trial tested a healthy Nordic pattern in adults with features of metabolic syndrome. Meals emphasised whole grains, berries, fruit, vegetables, rapeseed oil, fish and low-fat dairy. Over 18 to 24 weeks, the intervention improved some cholesterol measures compared with the control diet. Weight remained stable; insulin sensitivity and blood pressure did not improve significantly in the main analysis. Uusitupa and colleagues, University of Eastern Finland and collaborators, 2013.
These trials establish different, bounded findings. They cannot be compared as though they were a single contest: participants, control diets and study durations differed. Their usefulness lies in connecting a dietary change to a specified health measure.
Shared foods matter, but they do not prove a shared mechanism
Looking at the trial menus reveals considerable overlap: vegetables, fruit and low-fat dairy appear in both. The Nordic intervention also explicitly featured whole grains, fish and rapeseed oil. These are recognisable food choices, not a requirement to purchase specialised longevity products.
It is tempting to explain every favourable result through fibre, polyphenols or particular fats. But identifying nutrients in a menu does not show which component caused an outcome. Testing a dietary pattern changes several exposures together. Establishing a specific mechanism requires additional evidence.
Longer observational research helps connect eating patterns with outcomes closer to what readers actually want. A 2025 study involving Harvard researchers followed 105,015 participants for up to 30 years. Healthy ageing meant reaching 70 without specified major chronic diseases while maintaining cognitive, physical and mental health. Higher adherence to each of eight healthy dietary patterns was associated with greater odds of meeting that definition. Tessier and colleagues, 2025.
The study also associated higher consumption of fruit, vegetables, whole grains, nuts and legumes with healthier ageing. It remained observational, so differences in lifestyle and circumstances could contribute to the results.
Taken together, these findings support paying attention to overall food choices. They offer less support for replacing one sound eating pattern with another simply because a molecular analysis puts it ahead.
Personal experimentation: test whether the food fits your life
Personal experimentation can answer questions that population research cannot settle for you: whether you enjoy the meals, can afford the ingredients and can prepare them consistently. Keep that purpose explicit. An experiment in practicality is not proof that you have slowed ageing.
As a hypothetical example, someone interested in Nordic eating could try oats with berries for breakfast or incorporate a fish meal they enjoy. The immediate observations are ordinary but useful: preparation time, cost, satisfaction and whether the change lasts. None of these observations demonstrates a biological-age benefit.
If your reason for changing diet is elevated blood pressure or abnormal cholesterol, discuss the relevant pattern and follow-up measurements with your clinician. Existing dietary restrictions and treatment needs should guide those choices. A home experiment should not become a reason to change prescribed treatment.
If you already enjoy a varied, balanced eating pattern, the epigenetic findings alone provide no compelling reason to abandon it or purchase an ageing-clock test. A stronger reason to switch would be a specific health objective, relevant clinical evidence and meals you can sustain. Evidence that DASH or Nordic eating offers superior long-term outcomes over other healthy patterns would require a comparison designed to answer that question.
Sources
- German Centre for Neurodegenerative Diseases and collaborators, 2026. Diet quality, epigenetic ageing and the epigenome in two cohorts.
- Columbia University and collaborators, 2022. Development and validation of DunedinPACE.
- Columbia University and collaborators, 2023. Calorie restriction and DNA methylation measures in CALERIE.
- DASH Collaborative Research Group, 1997. Randomised trial of dietary patterns and blood pressure.
- University of Eastern Finland and collaborators, 2013. The randomised SYSDIET trial.
- Harvard University and collaborators, 2025. Dietary patterns and healthy ageing.
Text written with the help of AI.